Hantz Financial Services, Inc. Bio Techne Corp Transaction History

Hantz Financial Services, Inc.

$6.6 Billion
Q3 2025

A detailed history of Hantz Financial Services, Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 16,011 shares of TECH stock, worth $950,733. This represents 0.01% of its overall portfolio holdings.

Number of Shares

16,011

Previous 12,474 28.35%

Holding current value

$950,733

Previous $642,000 38.79%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 04, 2025	BUY	$49.87 - $58.78 $176,390 - $207,904	3,537 Added 28.35%	16,011 $891,000
Q2 2025 Aug 04, 2025	SELL	$46.66 - $58.38 $102,138 - $127,793	-2,189 Reduced 14.93%	12,474 $642,000
Q1 2025 May 12, 2025	BUY	$58.47 - $78.75 $27,305 - $36,776	467 Added 3.29%	14,663 $860,000
Q4 2024 Jan 23, 2025	BUY	$66.37 - $78.17 $15,663 - $18,448	236 Added 1.69%	14,196 $1.02 Million
Q3 2024 Nov 13, 2024	BUY	$70.96 - $82.35 $59,180 - $68,679	834 Added 6.35%	13,960 $1.12 Million

Q2 2024 Jul 30, 2024	BUY	$62.12 - $84.15 $815,387 - $1.1 Million	13,126 New	13,126 $940,000
Q1 2024 Aug 06, 2024	SELL	$65.98 - $77.09 $32,594 - $38,082	-494 Reduced 3.64%	13,079 $921,000
Q4 2023 Aug 06, 2024	SELL	$52.83 - $78.22 $33,969 - $50,295	-643 Reduced 4.52%	13,573 $1.05 Million
Q3 2023 Aug 06, 2024	BUY	$67.52 - $89.42 $36,730 - $48,644	544 Added 3.98%	14,216 $968,000
Q2 2023 Aug 06, 2024	BUY	$73.76 - $85.98 $19,988 - $23,300	271 Added 2.02%	13,672 $1.12 Million
Q1 2023 Aug 06, 2024	BUY	$71.62 - $86.62 $71,548 - $86,533	999 Added 8.06%	13,401 $994,000
Q4 2022 Aug 06, 2024	BUY	$80.67 - $352.29 $778,062 - $3.4 Million	9,645 Added 349.84%	12,402 $1.03 Million
Q3 2022 Aug 06, 2024	BUY	$282.54 - $391.85 $191,562 - $265,674	678 Added 32.61%	2,757 $783,000
Q2 2022 Aug 06, 2024	BUY	$322.67 - $449.65 $73,568 - $102,520	228 Added 12.32%	2,079 $721,000
Q1 2022 Aug 06, 2024	BUY	$353.85 - $487.79 $90,939 - $125,362	257 Added 16.12%	1,851 $802,000
Q4 2021 Aug 06, 2024	BUY	$456.15 - $525.06 $140,494 - $161,718	308 Added 23.95%	1,594 $825,000
Q3 2021 Aug 06, 2024	BUY	$444.87 - $538.88 $178,392 - $216,090	401 Added 45.31%	1,286 $623,000
Q2 2021 Aug 06, 2024	BUY	$387.35 - $450.26 $51,130 - $59,434	132 Added 17.53%	885 $398,000
Q1 2021 Aug 06, 2024	SELL	$314.62 - $411.0 $3.89 Million - $5.09 Million	-12,373 Reduced 94.26%	753 $288,000
Q4 2020 Aug 06, 2024	SELL	$246.9 - $321.87 $4,938 - $6,437	-20 Reduced 2.56%	762 $242,000
Q3 2020 Aug 06, 2024	BUY	$232.22 - $282.96 $464 - $565	2 Added 0.26%	782 $194,000
Q1 2020 Aug 06, 2024	SELL	$161.17 - $221.51 $1.99 Million - $2.73 Million	-12,346 Reduced 94.06%	780 $148,000

Others Institutions Holding TECH

# of Institutions

651

Shares Held

162M

Call Options Held

514K

Put Options Held

347K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.33B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.

Account

Hantz Financial Services, Inc. Bio Techne Corp Transaction History